ANXA2通过抑制自死亡从而改善心肌细胞缺氧/复氧损伤的实验研究OA
ANXA2 ameliorates hypoxia/reoxygenation injury of cardiomyocytes by inhibiting autosis
目的:自死亡作为一种自噬依赖性细胞死亡形式,在心肌缺血再灌注损伤(myocardial ischemia reperfusion injury,MIRI)中发挥"促生存"和"促死亡"的矛盾作用.基于自死亡途径,本研究旨在探讨膜联蛋白 A2(annexin A2,ANXA2)对 MIRI的影响及机制.方法:使用心肌细胞缺氧再复氧(hypoxia/reoxygenation,H/R)损伤模型模拟MIRI,构建靶向干预ANXA2的shRNA(shANXA2),采用CCK-8法检测细胞活力,通过共聚焦显微镜观察自噬小体、自噬溶酶体比例,使用Western blot检测自死亡相关蛋白表达.结果:ANXA2在心肌细胞H/R损伤后表达明显升高,下调ANXA2表达后转录因子EB(transcription factor EB,TFEB)核内表达增加,自噬小体比例降低,溶酶体比例升高,细胞活力恢复.Western blot结果显示,下调ANXA2 可降低ANXA2、p62 和LC3Ⅱ的蛋白水平,上调TFEB核内表达.结论:ANXA2 通过抑制TFEB的表达和核易位,影响自噬通量和自死亡发生,加剧心肌细胞H/R损伤.下调ANXA2可促进自噬通量,减少自死亡发生,从而减轻MIRI.本研究为ANXA2作为治疗MIRI的潜在靶点提供了实验依据.
Objective:Autosis,as a form of autophagy dependent cell death,plays a contradictory role in promoting survival and promoting death in myocardial ischemia-reperfusion injury(MIRI).The aim of this study was to investigate the effect of an-nexin A2(ANXA2)on MIRI and its mechanism by means of autosis.Methods:Cell hypoxia/reoxygenation(H/R)injury model was used to simulate MIRI,shRNA(shANXA2)targeting intervention was constructed,cell activity was detected by CCK-8,the ratio of autophagosome to autophagolysosome was observed by confocal microscopy,and autosis related protein expression was detected by Western blot.Results:The expression of ANXA2 was significantly increased in cardiomyocytes after H/R inju-ry,the expression of transcription factor EB(TFEB)was increased after downregulating ANXA2 expression,the proportion of autophagosomes was decreased,the proportion of lysosomes was increased,and cell viability was restored.Western blot results showed that down-regulation of ANXA2 decreased the levels of ANXA2,P62 and LC3II,and up-regulated the expression of TFEB.Conclusions:ANXA2 inhibits the expression of TFEB and nuclear translocation,affects autophagy flux and the occur-rence of autosis,and aggravates the H/R injury of cardiomyocytes.Down-regulation of ANXA2 promotes autophagy flux and re-duces the occurrence of autosis,thereby alleviating MIRI.This study provides experimental evidence for ANXA2 as a potential target for the treatment of MIRI.
许卫攀;李柳青;钟可文;金道群;刘滴
武汉科技大学黄石市中心医院研究生联合培养基地,湖北 黄石 435000||黄石市中心医院(湖北理工学院附属医院)心内科,湖北 黄石 435000||肾脏疾病发生与干预湖北省重点实验室,湖北 黄石 435000武汉科技大学医学部医学院,湖北 武汉 430081武汉科技大学医学部医学院,湖北 武汉 430081武汉科技大学黄石市中心医院研究生联合培养基地,湖北 黄石 435000||黄石市中心医院(湖北理工学院附属医院)心内科,湖北 黄石 435000||肾脏疾病发生与干预湖北省重点实验室,湖北 黄石 435000武汉科技大学黄石市中心医院研究生联合培养基地,湖北 黄石 435000||黄石市中心医院(湖北理工学院附属医院)心内科,湖北 黄石 435000||肾脏疾病发生与干预湖北省重点实验室,湖北 黄石 435000
医药卫生
自死亡心肌缺血再灌注损伤膜联蛋白A2(ANXA2)转录因子EB(TFEB)自噬通量
AutosisMyocardial ischemia-reperfusion injuryAnnexin A2(ANXA2)Transcription factor EB(TFEB)Autophagic flux
《海南医科大学学报》 2026 (5)
339-344,6
This study was supported by the Natural Science Foundation Project of Hubei Province(2022CFB159)Hubei Province Health and Family Planning Scientific Research Project(WJ2023F061)Hubei Polytechnic University Research Project(22xjz6Q)Huangshi Central Hospital Research Project(ZX2023M02) 湖北省自然科学基金面上项目(2022CFB159)湖北省卫生健康委科研资助(WJ2023F061)湖北理工学院校级科研项目(22xjz6Q)黄石市中心医院科研项目(ZX2023M02)
评论